Tamtam Try Tamtam free
McLaren Health Care logo

McLaren Health Care account plan

Comprehensive Michigan Health System

At a glance

McLaren Health Care is a Flint-based nonprofit Michigan health system with 12 hospitals, 3,100 licensed beds and health plans: $6.95 billion FY2025 revenue.

McLaren Health Care Corporation is a Flint, Michigan-based not-for-profit integrated health system: eleven regional McLaren hospitals plus Karmanos Cancer Center, ambulatory campuses, the McLaren Medical Group physician practice, an ACO and health plans in Michigan (McLaren Health Plan) and Indiana (MDwise). It has 3,100 licensed beds and in 2025 recorded 85,925 discharges, 398,705 ER visits and 3,718,068 ambulatory visits. FY2025 (year to September 30, 2025) total unrestricted revenue was $6,947,557K, of which patient service revenue $3,561,083K and premium revenue $2,958,629K; operating income more than doubled to $181,200K. Annual payroll is $1.91 billion. It is led by President and CEO Philip A. Incarnati.

Business units

Strategic priorities

Ambulatory growth
A $40 million Grand Ledge campus opened in October 2025 and a $53 million ambulatory, orthopedic and emergency center broke ground in Bay City, extending the Clarkston, Fenton, West Branch, Oxford and Cheboygan campus model.
Physician group acquisitions
McLaren offers group practices partnership as an alternative to private equity, acquired Park Medical Centers and plans more such group acquisitions.
Service line build-out
A new Heart & Vascular Institute covering all 12 hospitals plans up to 10 new or upgraded CT scanners, cath lab consolidation toward 80-85% utilization and an ECMO program at Flint.
AI in revenue cycle and prior authorization
SmarterPreBill uncovered $11.3 million in annualized new revenue, two revenue-cycle bots went live in 2025, and McLaren Health Plan wants to automate prior-auth decisions under the new CMS data-sharing rule.
NCI renewal at Karmanos
Karmanos submitted its five-year NCI comprehensive cancer center renewal in January 2026, with an answer expected late 2026 or early 2027.
Quality, finances and workforce
The CEO and Chairman name four priorities: quality and safety, strategic growth of services, financial strength, and a workplace that attracts, retains, respects and rewards employees.

Investments and deals

Capital spending
Purchases of property and equipment rose to $164,448K in FY2025 from $133,490K, with about $61 million committed to construction and financial and clinical IT projects.
Ambulatory campuses
The $40 million Grand Ledge campus (opened October 2025) and the $53 million Bay City ambulatory, orthopedic and emergency center.
Acquisitions
A medical center acquired in 2025 ($10,818K of goodwill) and the Park Medical Centers primary care group.
Digital pathology and cancer expansion
Digital pathology with Roche rolled out system-wide in July 2025; Karmanos opened Karmanos Dearborn and completed the Karmanos-Flint and Proton Therapy Center expansions in May 2025.

Challenges and risks

Loss of the MDwise Indiana contract
Indiana ended the MDwise Medicaid contract on December 31, 2025, a year early, removing about $1.7 billion of premium revenue, with about $293 million receivable from the State of Indiana.
Federal Medicaid cuts
Leaders flag the budget bill set to take more than $1.3 trillion away from Medicaid; most premiums come from Michigan and Indiana Medicaid, and the Michigan Hospital Assessment Program needs annual federal approval.
Research funding uncertainty
Karmanos faced the threat to cut NIH/NCI indirect funding and pulled-then-reinstated grants, which Pasche calls a year of stressful events for the academic community.
Unknown risk from new plan members
McLaren Health Plan's top risk is large payers exiting markets and leaving mid-size plans with members of unknown, higher risk.
Labor competition and compliance
Inflation and competition for nurses and technicians weigh on costs, and the single audit gave an adverse compliance opinion on a $1,350,000 grant over procurement procedures.

What leadership says

“We don't really view cost containment and member experience as trade offs.”

Patrick Stevenson, Vice President, Data and Technology, McLaren Health Plan · Becker's Payer Issues Podcast, May 29, 2026

“what we see today may not be what we'll we'll see next year”

Boris Pasche, President and CEO, Barbara Ann Karmanos Cancer Institute · Becker's Healthcare Podcast, August 21, 2026

“navigated a strong and steady path forward in 2025”

Philip A. Incarnati, President and CEO, and Daniel Boge, Chairman · Joint letter in the McLaren Health Care Annual Report 2025

Where a supplier can help

Ambulatory build-out
The Grand Ledge and Bay City campuses and the stated outpatient growth strategy need imaging, emergency, construction and clinic-operations suppliers.
Cardiology equipment
The Heart & Vascular Institute's plan for up to 10 new or upgraded CT scanners, cath lab consolidation and an ECMO program is a direct equipment and services opportunity.
Revenue-cycle and prior-auth automation
Proven gains from SmarterPreBill and the health plan's goal of automating prior authorization make AI and revenue-cycle vendors relevant to the financial-strength priority.
Member risk analytics
McLaren Health Plan's investment in predictive analytics and segmentation for rising-risk members suits care-management and population-health tools.
Offsetting lost premium revenue
Losing about $1.7 billion of MDwise premiums and Medicaid cut risk put a premium on cost-reduction, procurement and workforce-retention offers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like McLaren Health Care?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about McLaren Health Care

What is McLaren Health Care?

A Flint-based not-for-profit integrated health system in Michigan with 12 hospitals including Karmanos Cancer Center, ambulatory centers, an employed physician group and Medicaid health plans.

What is McLaren Health Care's revenue?

FY2025 (year to September 30, 2025) total unrestricted revenue was $6,947,557K, with operating income of $181,200K.

How big is McLaren's workforce and capacity?

It has 3,100 licensed beds, an annual payroll of $1.91 billion and over 600 providers in McLaren Medical Group.

What are McLaren's strategic priorities?

Quality and safety, strategic growth of services such as ambulatory campuses and service lines, financial strength, and attracting and retaining employees.

Who leads McLaren Health Care?

Philip A. Incarnati is President and CEO and Daniel Boge is Board Chairman; Dr. Boris Pasche leads Karmanos Cancer Institute.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)